Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Bliss GVS Pharma

BSE: 506197|NSE: BLISSGVS|ISIN: INE416D01022|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 16, 16:00
169.00
1.05 (0.63%)
VOLUME 78,712
LIVE
NSE
Jul 16, 15:48
167.55
0.3 (0.18%)
VOLUME 171,879
Announcements on Bliss GVS

23rd-May-2018 12:42Source: NSE

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated May 19, 2018, titled "Statement of Audited Financial Results for the Quarter and Financial Year ended 31.03.2018 in t...

18th-May-2018 09:00Source: NSE

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from August 18, 2018 to August 24, 2018 for the purpose of D...

17th-May-2018 20:38Source: BSE

Bliss GVS Pharma- Bliss GVS Pharma - Earnings Presentation - Q4-FY18

Bliss GVS Pharma - Earnings Presentation - Q4-FY18

17th-May-2018 20:06Source: BSE

Bliss GVS Pharma- Board recommends Final Dividend

Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 17, 2018, inter alia, has considered and approved the following:

1. Declared Final di...

17th-May-2018 19:55Source: BSE

Bliss GVS Pharma- Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from Saturday, 18th August, 2018 to...

17th-May-2018 19:50Source: BSE

Bliss GVS Pharma- Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31/03/2018

Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Annual Audited Financial Results (Standalone & Consolidated) for the q...

9th-May-2018 15:50Source: BSE

Bliss GVS Pharma- Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement

4th-May-2018 16:05Source: BSE

Bliss GVS Pharma- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015

20th-Apr-2018 11:16Source: NSE

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated April 18, 2018, titled "Kremoint Pharma Private Ltd., India, a 70% subsidiary of the parent company, Bliss GVS Pharma...

13th-Apr-2018 16:29Source: NSE

Bliss GVS Pharma Limited

Bliss GVS Pharma Limited has informed the Exchange regarding ''Update on Divestment of the Company’s Managed Healthcare Services Business in Kenya to Mayfair Healthcare Holdings Ltd.''.

1 2 3 4 5 Next >>
Quick Links for Bliss GVS Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.